US Patent 10875842 Inhibitors of KRAS G12C mutant proteins

Patent

US Patent 10246424 Substituted quinazoline compounds and methods of use thereof

US Patent 10273207 Covalent inhibitors of kras G12C

US Patent 10280172 Inhibitors of KRAS G12C mutant proteins

US Patent 10351550 Substituted quinazoline compounds and methods of use thereof

US Patent 10370386 Substituted quinolines as inhibitors of KRAS G12C

US Patent 10377743 Inhibitors of RAS and methods of use thereof

US Patent 10428064 Fused-tricyclic inhibitors of KRAS and methods of use thereof

US Patent 10414757 2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof

US Patent 10556906 Quinazoline compound

US Patent 10111874 Combination therapies for treatment of cancer

US Patent 12134620 Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer

US Patent 11358959 Benzothiophene and benzothiazole compounds and methods of use thereof

US Patent 11377441 Covalent inhibitors of KRAS

US Patent 11878985 Substituted quinazolines as inhibitors of KRAS G12C

US Patent 11021470 2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof

US Patent 11059819 Fused hetero-hetero bicyclic compounds and methods of use thereof

US Patent 11639346 Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS

US Patent 11274093 Fused bicyclic benzoheteroaromatic compounds and methods of use thereof

US Patent 11279689 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1 yl)prop-2-en-1-one derivatives and similar compounds as KRAS G12C modulators for treating cancer

United States Patent and Trademark Office

Po-Chih Chen